Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro
Por un escritor de hombre misterioso
Descripción
Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect
Robust Antiviral Activity of Santonica Flower Extract (Artemisia cina) against Avian and Human Influenza A Viruses: In Vitro and Chemoinformatic Studies
Frontiers Natural Plant Products: A Less Focused Aspect for the COVID-19 Viral Outbreak
Frontiers Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus
Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2
Advances in natural product anti-coronavirus research (2002-2022), Chinese Medicine
Artemisia annua L. hot-water extracts show potent activity in vitro against Covid-19 variants including delta - ScienceDirect
In vitro efficacy of Artemisia extracts against SARS-CoV-2, Virology Journal
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants
de
por adulto (el precio varía según el tamaño del grupo)